Roth Capital Has Negative Outlook for FIGS Q4 Earnings

FIGS, Inc. (NYSE:FIGS) – Investment analysts at Roth Capital dropped their Q4 2024 earnings per share (EPS) estimates for shares of FIGS in a report issued on Monday, November 4th. Roth Capital analyst M. Koranda now expects that the company will earn $0.03 per share for the quarter, down from their previous forecast of $0.04. The consensus estimate for FIGS’s current full-year earnings is $0.03 per share. Roth Capital also issued estimates for FIGS’s Q4 2025 earnings at $0.06 EPS and FY2026 earnings at $0.20 EPS.

FIGS (NYSE:FIGS) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.01 EPS for the quarter. The company had revenue of $144.23 million during the quarter, compared to analysts’ expectations of $142.25 million. FIGS had a return on equity of 4.94% and a net margin of 3.39%. FIGS’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.02 earnings per share.

Several other brokerages have also recently weighed in on FIGS. Telsey Advisory Group reissued a “market perform” rating and issued a $7.00 price objective on shares of FIGS in a report on Monday. The Goldman Sachs Group lifted their price target on shares of FIGS from $4.25 to $4.75 and gave the stock a “sell” rating in a research note on Friday, August 9th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $5.60.

FIGS Stock Performance

Shares of NYSE:FIGS opened at $6.41 on Tuesday. The stock’s 50-day simple moving average is $6.17 and its two-hundred day simple moving average is $5.71. The stock has a market capitalization of $1.10 billion, a price-to-earnings ratio of 64.10, a PEG ratio of 83.33 and a beta of 1.44. FIGS has a 52-week low of $4.30 and a 52-week high of $7.98.

Hedge Funds Weigh In On FIGS

Large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of FIGS by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 12,390,645 shares of the company’s stock valued at $86,115,000 after acquiring an additional 112,575 shares in the last quarter. Janney Montgomery Scott LLC lifted its holdings in shares of FIGS by 23.6% in the first quarter. Janney Montgomery Scott LLC now owns 16,977 shares of the company’s stock worth $85,000 after buying an additional 3,247 shares in the last quarter. ProShare Advisors LLC boosted its position in shares of FIGS by 26.6% during the first quarter. ProShare Advisors LLC now owns 766,465 shares of the company’s stock worth $3,817,000 after acquiring an additional 161,249 shares during the last quarter. Quadrature Capital Ltd bought a new stake in FIGS in the 1st quarter valued at $129,000. Finally, Price T Rowe Associates Inc. MD boosted its holdings in shares of FIGS by 6.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 63,141 shares of the company’s stock valued at $316,000 after purchasing an additional 4,038 shares during the last quarter. Hedge funds and other institutional investors own 92.21% of the company’s stock.

FIGS Company Profile

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.